Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen Polymtek Biomaterial is a high-tech enterprise specializing in the research, development, and manufacturing of medical-grade bioresorbable polymers. The company's product portfolio includes polylactic acid (PLA), polyglycolic acid (PGA), polycaprolactone (PCL), and their various copolymers, which are used extensively in orthopedics, tissue engineering, and controlled drug release systems. Polymtek provides high-purity materials that meet international standards for medical device manufacturers globally, supporting the production of absorbable sutures and fixation screws. Their expertise extends to customized polymer synthesis and advanced processing technologies to support innovative medical applications. The company is headquartered in Shenzhen, China, and operates under strict quality management systems including ISO 13485.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenzhen Polymtek Biomaterial.